Drugs
ImClone Systems Incorporated, a biopharmaceutical company focused on cancer research, announced a significant milestone in its collaboration with American Home Products Corporation. The company received a $500,000 payment from American Home Products, related to the filing of an Investigational New Drug (IND) application for a vaccine against Neisseria gonorrhea
Drugs
A detailed discussion on the terms of the American Home Products (AHP) Fen-Phen settlement will take place in San Francisco next month. Sponsored by Mealey Publications, the program will feature key attorneys involved in the settlement, medical experts, and a moderator to provide insight into the settlement's implications
Drugs
The bioscience sector is dynamic and carries the potential to bring significant benefits to society, but its message often fails to resonate with wider audiences due to misconceptions and concerns. In response, the BioIndustry Association (BIA) has introduced a Code of Best Practice, ratified by its members, to demonstrate accountability
Drugs
Despite government support and a strong scientific base, Canada's biotechnology industry is struggling to secure private sector investment, prompting fears of consolidation and potential business failures. The industry has grown rapidly since its inception, with around 280 biotechnology companies established in the country. However, most of these companies
Drugs
American Home Products Corporation, a world leader in research-based pharmaceutical and healthcare products, has received marketing approval from the UK Medicines Control Agency for the first conjugate vaccine against meningococcal Group C disease. This new vaccine, Meningitec(tm), will provide protection against meningococcal C meningitis, a life-threatening disease that causes
Drugs
Troubled retailer JCPenney Co. Inc. has sold its credit-card receivables operation to GE Capital, reducing its debt by approximately $3.8 billion to $4 billion. As part of the deal, GE Capital will provide private label credit-card services to JCPenney for the next 10 years. The sale was expected since
Drugs
As American Home Products' settlement of the Fen-Phen class action litigation is expected to be approved by the courts, attorneys are cautioning those who took the popular diet drug to protect their rights under the settlement agreement. The settlement, announced last week, will see American Home Products pay up
Drugs
Immunex Corporation has announced the appointment of Peggy Phillips as the company's new executive vice president and chief operating officer. Phillips will oversee the integration of the company's sales and marketing functions into a new operational unit, effectively aligning responsibility for a new product from clinical
Drugs
Attorney J. Douglas Peters of Charfoos & Christensen, P.C. announced that the Michigan Fen-Phen class action lawsuit against American Home Products and its affiliated companies has settled for $3.7 billion. However, this settlement does not apply to individuals whose products were manufactured by other companies. Cases against the
Drugs
A class-action lawsuit filed by New Jersey users of the fen-phen diet pill cocktail has been put on hold as negotiations for a national settlement progress. Anticipating a settlement, a judge discharged the jury that was hearing evidence in the case, stating that she "anticipates good news." The
Drugs
The FDA has identified several key areas of concern when inspecting process validation in the biotechnology industry. According to Gregory Bobrowicz, a former FDA investigator and compliance officer, four primary red flags include partial lack of validation, inadequate failure investigation, uncontrolled variation within specs, and problems with documentation. To address
Drugs
The US Food and Drug Administration (FDA) has cast a shadow over Abbott Laboratories by raising its second non-compliance concern in a year, this time regarding quality control at the company's Chicago plant that manufactures kits for medical diagnostic tests. The kits are used in testing fluids for
